GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algernon Pharmaceuticals Inc (XTER:BTI) » Definitions » Pretax Margin %

Algernon Pharmaceuticals (XTER:BTI) Pretax Margin % : % (As of May. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Algernon Pharmaceuticals Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Algernon Pharmaceuticals's Pre-Tax Income for the three months ended in May. 2024 was €0.98 Mil. Algernon Pharmaceuticals's Revenue for the three months ended in May. 2024 was €0.00 Mil. Therefore, Algernon Pharmaceuticals's pretax margin for the quarter that ended in May. 2024 was %.

The historical rank and industry rank for Algernon Pharmaceuticals's Pretax Margin % or its related term are showing as below:


XTER:BTI's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -153.96
* Ranked among companies with meaningful Pretax Margin % only.

Algernon Pharmaceuticals Pretax Margin % Historical Data

The historical data trend for Algernon Pharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algernon Pharmaceuticals Pretax Margin % Chart

Algernon Pharmaceuticals Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only - - - - -

Algernon Pharmaceuticals Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Algernon Pharmaceuticals's Pretax Margin %

For the Biotechnology subindustry, Algernon Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Algernon Pharmaceuticals's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Algernon Pharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Algernon Pharmaceuticals's Pretax Margin % falls into.



Algernon Pharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Algernon Pharmaceuticals's Pretax Margin for the fiscal year that ended in Aug. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Aug. 2023 )/Revenue (A: Aug. 2023 )
=-4.614/0
= %

Algernon Pharmaceuticals's Pretax Margin for the quarter that ended in May. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: May. 2024 )/Revenue (Q: May. 2024 )
=0.977/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Algernon Pharmaceuticals  (XTER:BTI) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Algernon Pharmaceuticals Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Algernon Pharmaceuticals's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Algernon Pharmaceuticals Business Description

Traded in Other Exchanges
Address
601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2
Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough. The company's business model is capital efficient and strives to deliver maximum shareholder value. Algernon's approach to drug discovery is based on the concept of drug repurposing. It operates in two reportable segments: the development of repurposed therapeutic drugs in Canada, and the facilitation of the Company's drug candidates into off-label phase II clinical trials (humans) in Australia.